Plenaxis Medicare National Coverage Decision Needed To Cement Prescriber Base, Praecis Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Providers are signing up to prescribe the prostate cancer drug through Praecis’ closed distribution system but waiting for a clear coverage determination before delivering the drug to patients, the company says. Praecis is proposing coverage for listed indications and clinical trials.